In the world's fight against antibiotic resistance, Bayer CEO Marijn Dekkers sees the need for a global antibiotics bailout.» Read More
A MoneyRates.com survey found 33 percent of workers expect to delay their retirement because of Obamacare, and just 19 percent expect to retire early.
What's next for Pfizer, now that its bid for AstraZeneca has been laid to rest, at least temporarily. Analysts weigh in with their views.
The World Health Organization called Tuesday for a hike in tobacco taxes to encourage smokers to quit and nonsmokers from starting.
GlaxoSmithKline says Britain's Serious Fraud Office (SFO) has opened a formal criminal investigation into its commercial practices.
Could things have turned out differently? Yes, according to one source in the AstraZeneca camp who pointed to a flaw in Pfizer's strategy.
Millions of Americans each year buy prescription medication from online, international pharmacies to save money even though it's illegal.
As debate rages over costly drugs like Gilead's Solvadi, patients caution: Treatment is priceless.
Here are some apps recommendations from "Valley Girl" Jesse Draper that can help you manage your health.
Many people who previously spent lots of money for prescriptions will be helped by Obamacare, but some may be surprised at what they still owe.
The mounting scrutiny of prescription drug prices in the U.S. reached fever pitch with total spending last year rising 3.2 percent, to $329.2 billion.
U.S. pharmaceutical giant releases statement confirming that it would not be making a further multibillion-dollar offer for its U.K. rival.
Express Scripts' Steve Miller has embarked on a drug pricing crusade, with the goal of bringing down costs.
People are more stressed out at home than they are at work, new research shows, but that may be because they are trying to juggle so much.
New research from the Consumer Financial Protection Bureau concludes that medical bills are unfairly lowering credit scores.
AstraZeneca is battling to shore up shareholder support to resist Pfizer's £69.4bn takeover as the US giant makes another push to revive the deal. The FT reports.
A possible White House move to bail out insurance companies would be a slip toward government domination of health care, Athenahealth CEO Jonathan Bush says.
Nevada's health-care exchange is cutting ties with Xerox and will partner with the federal system for 2015, the Las Vegas Review Journal reported.
Instead of criticizing foreign deals, we should be talking about corporate-tax reform to bring business—and jobs—back to the US, says Jake Novak.
In an interview with CNBC, Dr. Mehmet Oz also talked about what he considers the most underrated path to healthy living.
Part of the VA's problem is about supply and demand, and it's the same problem facing the country's health-care system, says Dr. Schnipper
Get the best of CNBC in your inbox